Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A link between gastrointestinal disorders and migraine: Insights into the gut–brain connection
Sheena K. Aurora, Stephen B. Shrewsbury, Sutapa Ray, et al.
Headache The Journal of Head and Face Pain (2021) Vol. 61, Iss. 4, pp. 576-589
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond
Andrew F. Russo, Debbie L. Hay
Physiological Reviews (2022) Vol. 103, Iss. 2, pp. 1565-1644
Open Access | Times Cited: 160
The Role of the Human Microbiome in the Pathogenesis of Pain
Klaudia Ustianowska, Łukasz Ustianowski, Filip Machaj, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13267-13267
Open Access | Times Cited: 48
Rebalancing NOX2/Nrf2 to limit inflammation and oxidative stress across gut-brain axis in migraine
Alessio Ardizzone, Anna Paola Capra, Alberto Repici, et al.
Free Radical Biology and Medicine (2024) Vol. 213, pp. 65-78
Open Access | Times Cited: 14
Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3‐month observational, longitudinal, cohort, multicenter, Italian real‐life study
Fabrizio Vernieri, Claudia Altamura, Nicoletta Brunelli, et al.
European Journal of Neurology (2021) Vol. 29, Iss. 4, pp. 1198-1208
Closed Access | Times Cited: 55
Altered amygdala effective connectivity in migraine without aura: evidence from resting‐state fMRI with Granger causality analysis
Xiaobin Huang, Di Zhang, Peng Wang, et al.
The Journal of Headache and Pain (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 51
Vagus nerve stimulation increases stomach-brain coupling via a vagal afferent pathway
Sophie J. Müller, Vanessa Teckentrup, Ignacio Rebollo, et al.
Brain stimulation (2022) Vol. 15, Iss. 5, pp. 1279-1289
Open Access | Times Cited: 34
Kynurenine Pathway of Tryptophan Metabolism in Migraine and Functional Gastrointestinal Disorders
Michał Fila, Jan Chojnacki, Elżbieta Pawłowska, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10134-10134
Open Access | Times Cited: 35
Altered gut microbiota in individuals with episodic and chronic migraine
Dongeun Yong, Hakbae Lee, Hyung-Gyu Min, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 15
Making migraine easier to stomach: the role of the gut−brain−immune axis in headache disorders
Marissa Sgro, Jason C. Ray, Emma Foster, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 11, pp. 3605-3621
Open Access | Times Cited: 13
Celecoxib Oral Solution and the Benefits of Self-Microemulsifying Drug Delivery Systems (SMEDDS) Technology: A Narrative Review
Stephen D. Silberstein, Egilius L.H. Spierings, Todd Kunkel
Pain and Therapy (2023) Vol. 12, Iss. 5, pp. 1109-1119
Open Access | Times Cited: 13
Phase Ib, open‐label, fixed‐sequence, drug–drug interaction, safety, and tolerability study between atogepant and ubrogepant in participants with a history of migraine
Andrew Blumenfeld, Ramesh Boinpally, Rosa De Abreu Ferreira, et al.
Headache The Journal of Head and Face Pain (2023) Vol. 63, Iss. 3, pp. 322-332
Open Access | Times Cited: 12
The correlation between vitamin B12 serum levels and migraine: a case-control study
Seham Eelsaid Abdelsadek, Sara Ahmed Tahoun, F Mansour, et al.
Neurological Research (2025), pp. 1-6
Closed Access
Key Targets of Brain-Gut Coordination in Wuzhuyu Decoction Treating Chronic Migraine Based on Proteomics
Meijing Li, Zhimin Song, Kristine Wang, et al.
(2025)
Closed Access
Physical-functional alterations in women with chronic migraine
Bruno Veloso Fracasso, Renato Bender Castro, Taís Malysz, et al.
Journal of Bodywork and Movement Therapies (2025)
Closed Access
Headache and Autonomic Dysfunction: a Review
Courtney Iser, Karissa N. Arca
Current Neurology and Neuroscience Reports (2022) Vol. 22, Iss. 10, pp. 625-634
Closed Access | Times Cited: 15
Delivery of Dihydroergotamine Mesylate to the Upper Nasal Space for the Acute Treatment of Migraine: Technology in Action
Wade M. Cooper, Sutapa Ray, Sheena K. Aurora, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery (2022) Vol. 35, Iss. 6, pp. 321-332
Open Access | Times Cited: 15
Cellular and Molecular Roles of Immune Cells in the Gut-Brain Axis in Migraine
Yichen Zhou, Miaoyi Pang, Yiran Ma, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 2, pp. 1202-1220
Closed Access | Times Cited: 7
Serum Calcitonin Gene-Related Peptide α and β Levels are Increased in COVID-19 Inpatients
Gabriel Gárate, Marta Pascual, Montserrat Rivero, et al.
Archives of Medical Research (2022) Vol. 54, Iss. 1, pp. 56-63
Open Access | Times Cited: 12
Pathophysiology of Syncope:Current Concepts and Their Development
David G. Benditt, Artur Fedorowski, Richard Sutton, et al.
Physiological Reviews (2024) Vol. 105, Iss. 1, pp. 209-266
Closed Access | Times Cited: 2
Enhancing Acute Migraine Treatment: Exploring Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for the Nose-to-Brain Route
Joana Torres, Renata Silva, Gonçalo Farias, et al.
Pharmaceutics (2024) Vol. 16, Iss. 10, pp. 1297-1297
Open Access | Times Cited: 2
Effects of probiotic and vitamin D co-supplementation on clinical symptoms, mental health, and inflammation in adult patients with migraine headache: a randomized, triple-blinded, placebo-controlled trial
Shahnaz Amani Tirani, Fariborz Khorvash, Parvane Saneei, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Practical supplements for prevention and management of migraine attacks: a narrative review
Zahra Hajhashemy, Sahar Golpour-Hamedani, Niloofar Eshaghian, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 2
Comparative bioavailability of single‐dose zavegepant during and between migraine attacks: A phase 1, randomized, open‐label, fixed‐sequence, two‐period study
Richard Bertz, Julie L. Collins, Jennifer Madonia, et al.
Headache The Journal of Head and Face Pain (2024)
Open Access | Times Cited: 2
Breath and Beyond: Advances in Nanomedicine for Oral and Intranasal Aerosol Drug Delivery
Simeng Du, Zhiyang Wen, Jinghan Yu, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1742-1742
Open Access | Times Cited: 2
A phase IV clinical trial of gastrointestinal motility in adult patients with migraine before and after initiation of a calcitonin gene‐related peptide ligand (galcanezumab) or receptor (erenumab) antagonist
David Kudrow, Linda Anh B. Nguyen, Jack Semler, et al.
Headache The Journal of Head and Face Pain (2022) Vol. 62, Iss. 9, pp. 1164-1176
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top